The Food and Drug Administration has the legal basis to restrict promotion of flawed comparative effectiveness research.

Persons

Aaron Seth Kesselheim

Venue / Journal

Health Aff (Millwood)

Date

Mon, 10/01/2012 - 12:00

Additional Journal Information

31(10):2200-5

Authors

Kesselheim AS, Avorn J.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/23048097